LungLife AI, Inc. (LLAI.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
LungLife AI, Inc.
Address
2545 West Hillcrest Drive
Thousand Oaks, CA 91320
United States of America (the)
Phone
805-409-9868
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
8
First IPO Date
July 08, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Paul Pagano | Chief Executive Officer, Chief Scientific Officer & Executive Director | 237,973 | 1985 |
| David Anderson | Chief Financial Officer, Company Secretary & Executive Director | 179,497 | 1963 |
Description
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
